Baird Medical Investment (NASDAQ:BDMD) Stock Price Down 1.9% - What's Next?

Key Points

• Baird Medical Investment Holdings Limited (NASDAQ:BDMD) experienced a 1.9% decline in stock price, closing at $2.10 after trading as low as $2.07.
• Wall Street Zen has downgraded the stock from a “hold” to a “sell” rating, indicating a bearish outlook on the company's performance.
• Institutional investors currently hold 19.78% of the company's shares, with notable increases in holdings by Geode Capital Management, XTX Topco Ltd, and Jane Street Group in recent quarters.

Shares of Baird Medical Investment Holdings Limited (NASDAQ:BDMD - Get Free Report) traded down 1.9% on Thursday . The company traded as low as $2.07 and last traded at $2.10. 52,525 shares changed hands during trading, a decline of 67% from the average session volume of 156,801 shares. The stock had previously closed at $2.14.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered Baird Medical Investment from a "hold" rating to a "sell" rating in a report on Monday, July 14th.

Baird Medical Investment Price Performance

The company has a fifty day simple moving average of $2.31 and a two-hundred day simple moving average of $4.03.

Institutional Trading of Baird Medical Investment

Several large investors have recently bought and sold shares of BDMD. Geode Capital Management LLC grew its holdings in Baird Medical Investment by 59.7% in the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company's stock valued at $93,000 after purchasing an additional 9,511 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Baird Medical Investment during the first quarter valued at $111,000. Finally, Jane Street Group LLC acquired a new stake in shares of Baird Medical Investment during the second quarter valued at $142,000. Institutional investors and hedge funds own 19.78% of the company's stock.

About Baird Medical Investment

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.